SCLXW vs. ATNFW, SXTPW, ACONW, ADEX, AIMDW, DRTSW, ALVOW, ALVO, AONCW, and AONC
Should you be buying Scilex stock or one of its competitors? The main competitors of Scilex include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Adit EdTech Acquisition (ADEX), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), and American Oncology Network (AONC). These companies are all part of the "medical" sector.
180 Life Sciences (NASDAQ:ATNFW) and Scilex (NASDAQ:SCLXW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation.
In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Scilex's score of 1.87 indicating that Scilex is being referred to more favorably in the news media.
180 Life Sciences and Scilex both received 0 outperform votes by MarketBeat users.
Summary
Scilex beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.
Get Scilex News Delivered to You Automatically
Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SCLXW vs. The Competition
Related Companies and Tools
